Comparison of the density of gamma-aminobutyric acid in the ventromedial prefrontal cortex of patients with first-episode psychosis and healthy controls

Shanghai Archives of Psychiatry

Volumn 27, Issue 6, 2015, Pages 341-347

  Yang, Zhilei ^a,b   Zhu, Yajing ^c   Song, Zhenhua ^a   Mei, Li ^a   Zhang, Jianye ^a   Chen, Tianyi ^a,d   Wang, Yingchan ^a   Xu, Yifeng ^a   Jiang, Kaida ^a   Li, Yao ^c   Liu, Dengtang ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Shanghai Jiading District Gynecological Endoscopy Center   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

^d Hongkou District Health Bureau   (China)

Author keywords

China; Drug na ve; First episode psychosis; First episode schizophrenia; Gamma aminobutyric acid; Magnetic resonance spectroscopy; Ventromedial prefrontal cortex

Indexed keywords

EID: 84961242158     PISSN: 10020829     EISSN: None     Source Type: Journal    
DOI: 10.11919/j.issn.1002-0829.215130     Document Type: Article

References (19)

1. Andreasen NC. Positive vs. negative schizophrenia: a critical evaluation. Schizophr Bull. 1985; 11(3): 380-389. doi: http://dx.doi.org/10.1093/schbul/11.3.380
2. Yang ZL, Liu DT. [Research progress of magnetic resonance spectroscopy in schizophrenia]. Jing Shen Yi Xue Za Zhi. 2015; 28(5): 393-396. Chinese. doi: http://dx.chinadoi.cn/10.3969/j.issn.2095-9346.2015.05.024
3. Benes FM, Berretta S. GABAergic interneurons: implications for understanding schizophrenia and bipolar disorder. Neuropsychopharmacol. 2001; 25(1): 1-27. doi: http://dx.doi.org/10.1016/S0893-133X(01)00225-1
4. Rowland LM, Kontson K, West J, Edden RA, Zhu H, Wijtenburg SA, et al. In vivo measurements of glutamate, GABA and NAAG in schizophrenia. Schizophr Bull. 2013; 39(5): 1096-1104. doi: http://dx.doi.org/10.1093/schbul/sbs092
5. Goto N, Yoshimura R, Moriya J, Kakeda S, Ueda N, Ikenouchi-Sugita A. Reduction of brain gamma-aminobutyric acid (GABA) concentrations in early-stage schizophrenia patients: 3T Proton MRS study. Schizophr Res. 2009; 112(1-3): 192-193. doi: http://dx.doi.org/10.1016/j.schres.2009.04.026
6. Taylor SF, Tso IF. GABA abnormalities in schizophrenia: a methodological review of in vivo studies. Schizophr Res. 2015; 167(1-3): 84-90. doi: http://dx.doi.org/10.1016/j.schres.2014.10.011
7. Mason MF, Norton MI, Van Horn JD, Wegner DM, Grafton ST, Macrae CN. Wandering minds: the default network and stimulus-independent thought. Science. 2007; 315(5810): 393-395. doi: http://dx.doi.org/10.1126/science.1131295
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 5th ed. Washington: American Psychiatric Association; 2013
9. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998; 59 (Suppl 20): 22-33
10. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987; 13(2): 261-76. doi: http://dx.doi.org/10.1093/schbul/13.2.261
11. Waddell KW, Avison MJ, Joers JM, Gore JC. A practical guide to robust detection of GABA in human brain by J-difference spectroscopy at 3 T using a standard volume coil. Magn Reson Imaging. 2007; 25(7): 1032-1038. doi: http://dx.doi.org/10.1016/j.mri.2006.11.026
12. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magnet Reson Med. 1993; 30(6): 672-679
13. Lisman JE, Coyle JT, Green RW, Javitt DC, Benes FM, Heckers S, et al. Circuit-based framework for understanding neurotransmitter and risk gene interactions in schizophrenia. Trends Neurosci. 2008; 31(5): 234-242. doi: http://dx.doi.org/10.1016/j.tins.2008.02.005
14. Lewis DA, Moghaddam B. Cognitive dysfunction in schizophrenia: convergence of gamma-aminobutyric acid and glutamate alterations. Arch Neurol. 2006; 63(10): 1372-1376. doi: http://dx.doi.org/10.1001/archneur.63.10.1372
15. Grobin AC, Deutch AY. Dopaminergic regulation of extracellular gamma-aminobutyric acid levels in the prefrontal cortex of the rat. J Pharmacol Exp Ther. 1998; 285(1): 350-357
16. Bourdelais AJ, Deutch AY. The effects of haloperidol and clozapine on extracellular GABA levels in the prefrontal cortex of the rat: an in vivo microdialysis study. Cereb Cortes. 1994; 4(1): 69-77. doi: http://dx.doi.org/10.1093/cercor/4.1.69
17. Tayoshi S, Nakataki M, Sumitani S, Taniguchi K, Shibuya-Tayoshi S, Numata S, et al. GABA concentration in schizophrenia patients and the effects of antipsychotic medication: a proton magnetic resonance spectroscopy study. Schizophr Res. 2010; 117(1): 83-91. doi: http://dx.doi.org/10.1016/j.schres.2009.11.011
18. Choe BY, Kim KT, Suh TS, Lee P, Paik IH, Bahk YW. 1H magnetic resonance spectroscopy characterization of neuronal dysfunction in drug-naïve, chronic schizophrenia. Acad Radiol. 1994; 1(3): 211-216
19. Kegeles LS, Mao XL, Stanford AD, Girgis R, Ojeil N, Xu XY, et al. Elevated prefrontal cortex (gamma) - aminobutyric acid and glutamate - glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy. Arch Gen Psychiatry. 2012; 69(5): 449-459. doi: http://dx.doi.org/10.1001/archgenpsychiatry.2011.1519